PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CORT vs. AXSM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

CORT vs. AXSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corcept Therapeutics Incorporated (CORT) and Axsome Therapeutics, Inc. (AXSM). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%100.00%JuneJulyAugustSeptemberOctoberNovember
88.56%
22.20%
CORT
AXSM

Returns By Period

In the year-to-date period, CORT achieves a 67.20% return, which is significantly higher than AXSM's 19.94% return.


CORT

YTD

67.20%

1M

9.16%

6M

88.56%

1Y

109.35%

5Y (annualized)

33.28%

10Y (annualized)

33.73%

AXSM

YTD

19.94%

1M

2.26%

6M

22.20%

1Y

58.99%

5Y (annualized)

22.93%

10Y (annualized)

N/A

Fundamentals


CORTAXSM
Market Cap$5.51B$4.52B
EPS$1.26-$6.58
PEG Ratio0.610.00
Total Revenue (TTM)$628.56M$338.46M
Gross Profit (TTM)$618.75M$306.46M
EBITDA (TTM)$144.55M-$302.65M

Key characteristics


CORTAXSM
Sharpe Ratio2.021.40
Sortino Ratio2.372.03
Omega Ratio1.361.25
Calmar Ratio2.921.34
Martin Ratio6.143.80
Ulcer Index17.86%15.62%
Daily Std Dev54.26%42.42%
Max Drawdown-94.28%-86.65%
Current Drawdown-8.88%-10.15%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.2

The correlation between CORT and AXSM is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

CORT vs. AXSM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CORT, currently valued at 2.02, compared to the broader market-4.00-2.000.002.004.002.021.40
The chart of Sortino ratio for CORT, currently valued at 2.37, compared to the broader market-4.00-2.000.002.004.002.372.03
The chart of Omega ratio for CORT, currently valued at 1.36, compared to the broader market0.501.001.502.001.361.25
The chart of Calmar ratio for CORT, currently valued at 2.92, compared to the broader market0.002.004.006.002.921.34
The chart of Martin ratio for CORT, currently valued at 6.14, compared to the broader market-10.000.0010.0020.0030.006.143.80
CORT
AXSM

The current CORT Sharpe Ratio is 2.02, which is higher than the AXSM Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of CORT and AXSM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50JuneJulyAugustSeptemberOctoberNovember
2.02
1.40
CORT
AXSM

Dividends

CORT vs. AXSM - Dividend Comparison

Neither CORT nor AXSM has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CORT vs. AXSM - Drawdown Comparison

The maximum CORT drawdown since its inception was -94.28%, which is greater than AXSM's maximum drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for CORT and AXSM. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-8.88%
-10.15%
CORT
AXSM

Volatility

CORT vs. AXSM - Volatility Comparison

Corcept Therapeutics Incorporated (CORT) has a higher volatility of 16.12% compared to Axsome Therapeutics, Inc. (AXSM) at 12.32%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
16.12%
12.32%
CORT
AXSM

Financials

CORT vs. AXSM - Financials Comparison

This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items